Research Progress Concerning Dual Blockade of Lymphocyte-Activation Gene 3 and Programmed Death-1/Programmed Death-1 Ligand-1 Blockade in Cancer Immunotherapy: Preclinical and Clinical Evidence of This Potentially More Effective Immunotherapy Strategy

Although various immunotherapies have exerted promising effects on cancer treatment, many patients with cancer continue to exhibit poor responses. Because of its negative regulatory effects on T cells and its biological functions related to immune and inflammatory responses, there has been considera...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Yihang, Chen, Li, Liu, Qiang, Kong, Xiangyi, Fang, Yi, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820761/
https://www.ncbi.nlm.nih.gov/pubmed/33488573
http://dx.doi.org/10.3389/fimmu.2020.563258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820761/
https://www.ncbi.nlm.nih.gov/pubmed/33488573
http://dx.doi.org/10.3389/fimmu.2020.563258

Ejemplares similares